In gastric cancer, overexpressed fibroblast growth factor receptor 4 (FGFR4) forms a complex with p62 and KEAP1, which blocks KEAP1-mediated NRF2 ubiquitination and degradation. Here, FGFR4 is linked to gastric cancer.